Dr. Mohammed Alaouna is a Postdoctoral Research Fellow at the Pan African Cancer Research Institute (PACRI), University of Pretoria, with a PhD in Cancer Biology from the University of the Witwatersrand (2024). His research focuses on the therapeutic potential of indigenous South African plant extracts, particularly Tulbaghia violacea and Cotyledon orbiculata, for treating triple-negative breast cancer. Dr. Alaouna possesses expertise in advanced laboratory techniques including RNA sequencing, qPCR, western blotting, and flow cytometry, while also being proficient in bioinformatics and programming languages such as Python and R. Currently contributing to the SAMBAI project (Societal, Ancestry, Molecular and Biological Analyses of Inequalities) funded by Cancer Research UK, he is dedicated to addressing cancer disparities in marginalized populations through innovative translational research. His work, published in multiple peer-reviewed journals, reflects his commitment to developing equitable cancer therapies that improve global health outcomes.